Tag:
clivatuzumab tetraxetan
Latest Headlines
Latest Headlines
FDA slams brakes on Immunomedics' cancer trial
Here's one way to threaten the timeline for a clinical study. The FDA has halted Immunomedics' ( $IMMU ) clinical trial of a therapy called clivatuzumab tetraxetan for pancreatic cancer because one
